Suchergebnisse - "Tao, Lihong"

PubPharm (45)

1

Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1

enthalten in: Nature communications | 2024

von Khan, I. | Li, S. | Tao, L. | +15

2

Steroid compound and application thereof in treatment of neurodegenerative diseases

enthalten in: Europäisches Patentamt | 2023

von TANG TIEYU | HUANG YUMIN | WANG YINGGE | +3

3

Steroid compound and application thereof in treatment of neurodegenerative diseases

enthalten in: Europäisches Patentamt | 2023

von TANG TIEYU | HUANG YUMIN | WANG YINGGE | +3

4

BushenHuoxue decoction suppresses M1 macrophage polarization and prevents LPS induced inflammatory bone loss by activating AMPK pathway

enthalten in: Heliyon | 2023

von Chen, S. | Tao, L. | Zhu, F. | +11

5

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway

enthalten in: Cell proliferation | 2022

von Li, Y. | Zhuang, Q. | Tao, L. | +11

6

Skin treatment traditional Chinese medicine with beautifying and maintaining effects and preparation method of skin treatment traditional Chinese medicine

enthalten in: Europäisches Patentamt | 2022

von ZHANG DAFANG | CHEN SHUANGSHUANG | TAO LIHONG | +2

7

Clinical characteristics of cognitive impairment and its related risk factors in post-stroke epilepsy

enthalten in: Epileptic disorders : international epilepsy journal with videotape | 2022

von Hou, H. | Sun, G. | Duan, Z. | +3

8

Generation of SIV resistant T cells and Macrophages from Nonhuman Primate Induced Pluripotent Stem Cells with Edited CCR5 locus

enthalten in: bioRxiv.org | 2022

von D’Souza, S. | Kumar, A. | Weinfurter, J. | +8

9

Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus

enthalten in: Stem cell reports | 2022

von D'Souza, S. | Kumar, A. | Weinfurter, J. | +9

10

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/ NF‐κB pathway

enthalten in: Cell Proliferation | 2022

von Li, Y. | Zhuang, Q. | Tao, L. | +11

1
2
3
4
5
Nächster »
[5]